A chronic inflammatory bowel disease characterized by continuous mucosal inflammation of the colon, extending proximally from the rectum. Unlike crohns disease, UC is limited to the colon, affects only the mucosa/submucosa (not transmural), produces no skip lesions, and has no granulomas. From a metallomics perspective, UC presents a distinct metal signature from Crohn's, driven by chronic blood loss, mucosal inflammation, and a microbiome collapse that differs in character from the Crohn's pattern.
Metallomic Signature
Iron -- The Bleeding Metal
Iron deficiency is the dominant metal abnormality in UC, driven by chronic mucosal bleeding:
- Prevalence: 60-80% of active UC patients have iron deficiency; 30-40% have frank anemia
- Mechanism: Chronic blood loss from ulcerated mucosa + hepcidin elevation from inflammation → functional iron deficiency even with adequate stores
- The iron paradox: Oral iron supplementation worsens UC by feeding iron-dependent pathobionts (E. coli, Klebsiella), increasing oxidative stress in the inflamed mucosa, and shifting the microbiome toward dysbiosis. IV iron bypasses the gut but still raises hepcidin.
- Ferritin is unreliable as an iron marker in UC (acute phase reactant; elevated by inflammation)
Copper -- Elevated in Active Disease
- Serum copper and ceruloplasmin rise during UC flares (acute phase response)
- Tissue copper may be depleted despite elevated serum levels
- Cu/Zn ratio is elevated and correlates with disease activity
- Ceruloplasmin's ferroxidase activity links copper to iron handling
Zinc -- Depleted and Protective
- Serum zinc is consistently low in active UC
- Zinc deficiency impairs mucosal healing, reduces tight junction integrity, and weakens antimicrobial peptide (defensin) production
- Zinc supplementation in UC improves barrier function and reduces relapse in small trials
- ZIP8 transporter polymorphism (A391T) alters zinc handling in the gut — see crohns disease for the genetics
Selenium -- Deficient with Consequences
- Selenium deficiency is common in UC and correlates with disease severity
- Se is required for glutathione peroxidase (antioxidant defense in inflamed mucosa)
- Se deficiency impairs Treg function (see immune balance), potentially perpetuating the autoimmune component
Microbiome in UC
UC has a characteristic dysbiotic signature:
Depleted Taxa
- Faecalibacterium prausnitzii — the most consistently depleted taxon in UC; produces butyrate, has direct anti-inflammatory effects (IL-10 induction); its absence is a hallmark of active disease
- Roseburia — another major butyrate producer lost in UC
- Bacteroides — reduced diversity within this genus
- Overall diversity — alpha diversity reduced, particularly during flares
Enriched Taxa
- Escherichia coli — especially adherent-invasive E. coli (AIEC); enriched in inflamed mucosa; high iron requirement fuels expansion when mucosal bleeding provides iron
- Enterococcus — expands in the depleted ecosystem
- Fusobacterium — associated with colorectal neoplasia in longstanding UC
- Ruminococcus gnavus — mucin degrader enriched in UC flares
Metabolic Consequences
- short chain fatty acids (especially butyrate) are profoundly reduced in UC
- Butyrate is the primary fuel for colonocytes — its depletion creates an energy crisis in the epithelium
- Reduced SCFA → weakened barrier function → increased translocation → more inflammation → a vicious cycle
- Bile acid metabolism is altered (reduced secondary bile acids from microbial deconjugation)
Distinguishing UC from Crohn's: The Metallomic View
| Feature | Ulcerative Colitis | crohns disease |
|---|---|---|
| Iron deficiency | Dominant (bleeding) | Present (malabsorption) |
| Copper | Elevated (acute phase) | Variable |
| Zinc | Depleted | Depleted + ZIP8 genetic link |
| Selenium | Depleted | Depleted |
| calprotectin | Very high (>250 mcg/g in active) | High but more variable |
| Key depleted taxa | F. prausnitzii, Roseburia | F. prausnitzii + broader loss |
| Key enriched taxa | E. coli, Enterococcus | AIEC, Ruminococcus gnavus |
| FMT evidence | Stronger (multiple positive RCTs) | Weaker (case series) |
Fecal Microbiota Transplantation (FMT)
UC has the strongest FMT evidence of any IBD subtype:
- Multiple RCTs show clinical remission in 25-35% of UC patients (vs. 5-10% placebo)
- Donor microbiome diversity predicts response — donors with high Lachnospiraceae and Ruminococcaceae abundance produce better outcomes
- FMT restores butyrate production and F. prausnitzii populations
- Metal implications: FMT may normalize the metal-handling capacity of the microbiome (metal-binding, biotransformation), though this is unstudied
The Iron-Pathobiont Feedback Loop
A UC-specific vicious cycle:
- Mucosal ulceration → bleeding → luminal iron excess
- Luminal iron feeds iron-dependent E. coli and Enterobacteriaceae
- Pathobiont expansion → more inflammation → more tissue damage
- More bleeding → more luminal iron → cycle accelerates
- Simultaneously, systemic iron deficiency worsens (blood loss outpaces absorption)
This explains why oral iron is generally avoided during active UC flares and why iron-restricted pathobiont control is a recognized research target.
<!— Intervention/treatment content moved to Cureva per public/clinical boundary policy —>
Key Sources
Connections
- inflammatory bowel disease — the parent category; UC is the mucosal-limited colonic subtype
- crohns disease — the key differential; distinct metal signature and microbiome pattern
- iron — dominant metal abnormality; chronic mucosal bleeding drives deficiency; oral iron feeds pathobionts
- zinc — depleted in active UC; supplementation improves barrier function and reduces relapse
- copper — elevated serum Cu during flares (acute phase response); Cu/Zn ratio tracks disease activity
- selenium — deficiency common and correlates with severity; required for antioxidant defense
- calprotectin — primary non-invasive biomarker; very high (>250 mcg/g) in active disease
- dysbiosis — F. prausnitzii and Roseburia depletion; E. coli and Enterococcus enrichment
- short chain fatty acids — profound butyrate reduction creates colonocyte energy crisis
- intestinal permeability — barrier dysfunction central to the inflammation-translocation vicious cycle
- immune balance — Th17/Treg imbalance perpetuates mucosal inflammation
- fecal microbiota transplant — strongest FMT evidence of any IBD subtype; 25-35% clinical remission
- probiotics — VSL#3 for maintaining remission; E. coli Nissle 1917 efficacy comparable to mesalazine
- pharmacomicrobiomics — bacterial azoreductases convert sulfasalazine to active 5-ASA